Stocks on Wall Street rose for the first time in four sessions Wednesday.
Spurring them higher: President Donald Trump's remarks that trade talks with China were going "very well." Energy stocks led the broad-based rally, pushing the S&P 500 up more than half percent.
Edward Jones investment strategist, Nela Richardson: SOUNDBITE: EDWARD JONES INVESTMENT STRATEGIST, NELA RICHARDSON (ENGLISH) SAYING: "Investors should expect more volatility.
So more of the same next year.
It doesn't wash away with an interim deal or a tweet or a change in rhetoric.
What investors should look for is actual change in actions like a removal or roll back of the existing tariffs and no new tariffs." Shares of online travel agency Expedia among the biggest gainers on the S&P 500.
Its CEO and finance head resigned after clashing with the board over strategy.
Wall Street lost ground on Tuesday, with halted COVID-19 vaccine trials and an elusive U.S. stimulus agreement weighing on sentiment as third quarter earnings season got underway. Fred Katayama reports.
U.S. stocks fell sharply Tuesday to close lower after President Donald Trump said he was calling off negotiations with Democratic lawmakers on coronavirus relief legislation until after the election. Fred Katayama reports.
Future tax policy, fiscal spending and budget deficit reduction plans are some of the key things Wall Street will be listening for in the first 2020 U.S. presidential debate, chief investment officer Hugh Johnson told Reuters business correspondent Conway G. Gittens.
Unlike years prior where the first couple would hand out candy to trick-or-treaters, U.S. President Donald Trump and first lady Melania presided over a 2020 White House Halloween costume parade where youngsters waved and posed from social distances.
President Donald Trump's daughter and son-in-law, both top White House aides, are threatening to sue a group of anti-Trump Republicans for posting billboard ads in New York City's Times Square linking them to the country's almost 225,000 coronavirus deaths. Gavino Garay reports.
[NFA] The Republican-controlled U.S. Senate on Sunday moved closer to a final confirmation vote expected Monday on President Donald Trump's Supreme Court nominee, Amy Coney Barrett, just over a week before Election Day. Gavino Garay reports.
AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on Friday. Fred Katayama reports.
Mattel reported a surprise rise in quarterly sales on Thursday and forecast more growth in the holiday season, as retailers rushed to restock their shelves of Barbie dolls and other toys in high demand from stuck-at-home kids. Fred Katayama reports.
A California appeals court on Thursday unanimously ruled against ride-hailing companies Uber Technologies and Lyft, saying they must reclassify their drivers in the state as employees. Fred Katayama reports.
The S&P 500 posted a nominal gain on Friday as further clarity regarding the timeline for the development of a coronavirus vaccine and much better-than-expected retail sales data brought buyers back to the market. Fred Katayama reports.
Stock market analysts always worry around the time of a Presidential election. The markets can react unpredictably when a certain candidate gets elected. According to Stifel the S&P 500 will sell off initially if the Senate or Presidency remains Republican after the election. Business Insider reports that a note from Stifel says the S&P may fall following this election outcome. With the Republicans in charge hopes of a large fiscal stimulus will fade.
The S&P 500 ended lower on Thursday after a rise in weekly jobless claims compounded worries about a stalling economic recovery and fading hopes for more fiscal aid before the election. Fred Katayama reports.
On Tuesday, JPMorgan's Grace Peters told CNBC's "Squawk Box Europe" the S&P 500 could hit 3,750 by September 2021. Business Insider reports that would represent a 12% premium over Tuesday's closing price of 3,335.47. On the outlook for US stocks, she said, "We can see around a 10% upside over a 12-month view." Peters said investors should look at areas that have seen "structural growth" like construction, healthcare, and digital-transformation.
Business Insider reports that US stocks are on course to close lower for a third consecutive week. The S&P 500 has lost nearly 9% since early September's record high. That decline was mainly driven by losses in the technology sector. But Goldman Sachs, Wells Fargo and Deutsche Bank are upbeat the US stock market sell-off is mostly over. Goldman Sachs kept its end-of year S&P 500 target to 3,600 by year end.
Getty Images US stocks extended losses into Monday's close as a lack of stimulus progress cut into hopes for a pre-election deal. House Speaker Nancy Pelosi expedited talks on Sunday, setting a 48-hour deadline for the White House and Democrats to ink a deal. She later told Democrats that significant obstacles in reaching a compromise remain. Even if an agreement is reached, the bill is set to die in the Senate as Republicans push a $500 billion measure.
Wall Street's main indexes hit their lowest in nearly seven weeks Monday as concerns about fresh coronavirus-driven lockdowns and the inability of Congress to agree on more fiscal stimulus raised fears about another hit to the domestic economy. Fred Katayama reports.
Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a safety concern. This report produced by Jillian Kitchener.
The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Gavino Garay reports.
An independent panel of experts has been formed in California to review any federally approved Covid-19 vaccine. The move follows concerns that the White House could rush the process. Flora Bradley-Watson reports.
[NFA] Twitter took down a post by a top coronavirus task force adviser who questioned whether masks worked to cut down on transmission of the respiratory illness. This report produced by Zachary Goelman.
U.S. drug inspectors uncovered serious quality control problems at an Eli Lilly pharmaceutical plant that is ramping up to manufacture one of two promising COVID-19 drugs touted by President Trump as "a cure" for the disease, according to government documents and three sources familiar with the matter. Jillian Kitchener reports
FILE PHOTO: Traders work on the floor at the New York Stock Exchange (NYSE) in New York, U.S., December 17, 2019. The Dow Jones Industrial Average fell 36.08 points, or 0.13%, to 28,515.45, the S&P 500..